HCA Healthcare, Inc. 8K

HCA Healthcare, Inc. reported Q2 2026 results, detailed payer and Medicaid program impacts, cut full-year 2026 guidance, and declared a $0.78 quarterly dividend.

On July 24, 2026, HCA Healthcare, Inc. reported its financial and operating results for the second quarter and six months ended June 30, 2026, showing 8.7% year-over-year revenue growth to $20.23 billion, a 2.8% increase in net income attributable to the company to $1.699 billion and adjusted EBITDA of $4.027 billion, while highlighting a significant adverse $400 million pre-tax impact from a payer mix shift tied to increased uninsured volumes from health insurance exchange coverage losses, a favorable roughly $400 million incremental net benefit from Medicaid Supplemental Payment Programs (primarily from Florida’s directed payment program, including substantial prior-period revenue), reduced cash flow from operations versus the prior year, continued heavy capital spending and share repurchases, declaration of a $0.78 per share quarterly dividend payable September 30, 2026, and a downward revision to full-year 2026 guidance for revenue, net income, adjusted EBITDA and diluted EPS based on updated assumptions for greater negative exchange-related payer mix impacts partially offset by higher expected Medicaid supplemental payments.

Filing Facts

CIK

860730

Ticker

HCA

Form

8K

Source Type

sec

Accession

0001193125-26-315151

Alert Tier

7